{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:34:59Z","timestamp":1788863699471,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008035","name":"Njurfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20160384"],"award-info":[{"award-number":["20160384"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-00932"],"award-info":[{"award-number":["2018-00932"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) is linked to an increased cardiovascular disease (CVD) burden. Albeit underappreciated, sex differences are evident in CKD with females being more prone to CKD development, but males progressing more rapidly to kidney failure (KF). Cardiovascular remodelling is a hallmark of CKD with increased arterial and valvular calcification contributing to CKD. However, little is known regarding sex differences in calcific cardiovascular remodelling in KF patients. Thus, we hypothesise that sex differences are present in coronary artery calcification (CAC) and aortic valve calcification (AVC) in patients with KF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>KF patients, males (n\u2009=\u2009214) and females (n\u2009=\u2009107), that had undergone computer tomography (CT) assessment for CAC and AVC were selected from three CKD cohorts. All patients underwent non-contrast multi-detector cardiac CT scanning, with CAC and AVC scoring based on the Agatston method. Baseline biochemical measurements were retrieved from cohort databases, including plasma analyses for inflammation markers (IL-6, TNF, hsCRP) and oxidative stress by skin autofluorescence measuring advanced glycation end-products (AGE), amongst other variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sex-disaggregated analyses revealed that CAC score was associated with age in both males and females (both p\u2009&lt;\u20090.001). Age-adjusted analyses revealed that in males CAC was associated with diabetes mellitus (DM) (p\u2009=\u20090.018) and CVD (p\u2009=\u20090.011). Additionally, for females CAC associated with IL-6 (p\u2009=\u20090.005) and TNF (p\u2009=\u20090.004). In both females and males CAC associated with AGE (p\u2009=\u20090.042 and p\u2009=\u20090.05, respectively). CAC was associated with mortality for females (p\u2009=\u20090.015) independent of age. AVC in females was not reviewed due to low AVC-positive samples (n\u2009=\u200914). In males, in multivariable regression AVC was associated with age (p\u2009&lt;\u20090.001) and inflammation, as measured by IL-6 (p\u2009=\u20090.010).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In female KF patients inflammatory burden and oxidative stress were associated with CAC. Whereas in male KF patients oxidative stress and inflammation were associated with CAC and AVC, respectively. Our findings suggest a sex-specific biomarker signature for cardiovascular calcification that may affect the development of cardiovascular complications in males and females with KF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13293-023-00530-x","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T17:02:21Z","timestamp":1689267741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Coronary artery calcification and aortic valve calcification in patients with kidney failure: a sex-disaggregated study"],"prefix":"10.1186","volume":"14","author":[{"given":"Liam J.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agne","family":"Laucyte-Cibulskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonaz","family":"Ripsweden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GOING-FWD Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pilote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Trinidad","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-6836","authenticated-orcid":false,"given":"Karolina","family":"Kublickiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"12","key":"530_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"2011","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;2011(12):7\u201311.","journal-title":"Kidney Int Suppl"},{"key":"530_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395:709\u201333.","journal-title":"The Lancet"},{"key":"530_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","volume":"99","author":"P D\u00fcsing","year":"2021","unstructured":"D\u00fcsing P, et al. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl). 2021;99:335\u201348.","journal-title":"J Mol Med (Berl)"},{"key":"530_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa006","author":"L Dai","year":"2020","unstructured":"Dai L, Schurgers LJ, Shiels PG, Stenvinkel P. Early vascular ageing in chronic kidney disease: Impact of inflammation, Vitamin K, senescence and genomic damage. Nephrol Dial Transplant. 2020. https:\/\/doi.org\/10.1093\/ndt\/gfaa006.","journal-title":"Nephrol Dial Transplant"},{"key":"530_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/toxins11020082","volume":"11","author":"S Hobson","year":"2019","unstructured":"Hobson S, Arefin S, Kublickiene K, Shiels PG, Stenvinkel P. Senescent cells in early vascular ageing and bone disease of chronic kidney disease\u2014a novel target for treatment. Toxins (Basel). 2019;11:82.","journal-title":"Toxins (Basel)"},{"key":"530_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, Fang Y. The chronic kidney disease\u2014Mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone"},{"key":"530_CR7","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1523-1755.2005.00239.x","volume":"67","author":"D Veit Barreto","year":"2005","unstructured":"Veit Barreto D, et al. Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors. Kidney Int. 2005;67:1576\u201382.","journal-title":"Kidney Int"},{"key":"530_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-015-0270-3","author":"CH Byon","year":"2015","unstructured":"Byon CH, Chen Y. Molecular mechanisms of vascular calcification in chronic kidney disease: the link between bone and the vasculature. Curr Osteoporos Rep. 2015. https:\/\/doi.org\/10.1007\/s11914-015-0270-3.","journal-title":"Curr Osteoporos Rep."},{"key":"530_CR9","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1038\/s41598-020-63013-8","volume":"10","author":"AMG Jaminon","year":"2020","unstructured":"Jaminon AMG, et al. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease. Sci Rep. 2020;10:6586.","journal-title":"Sci Rep"},{"key":"530_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/j.ackd.2019.10.004","volume":"26","author":"VM Brandenburg","year":"2019","unstructured":"Brandenburg VM, Schuh A, Kramann R. Valvular calcification in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26:464\u201371.","journal-title":"Adv Chronic Kidney Dis"},{"key":"530_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","volume":"55","author":"P Stenvinkel","year":"1999","unstructured":"Stenvinkel P, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899\u2013911.","journal-title":"Kidney Int"},{"key":"530_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3747\/pdi.2013.00259","volume":"35","author":"H Xu","year":"2015","unstructured":"Xu H, et al. Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients. Perit Dial Int. 2015;35:206.","journal-title":"Perit Dial Int"},{"key":"530_CR13","unstructured":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease."},{"key":"530_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-021-00393-0","volume":"12","author":"A Laucyte-Cibulskiene","year":"2021","unstructured":"Laucyte-Cibulskiene A, et al. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality. Biol Sex Differ. 2021;12:1\u201311.","journal-title":"Biol Sex Differ"},{"key":"530_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ndt\/gfx371","volume":"34","author":"H Mukai","year":"2019","unstructured":"Mukai H, et al. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study. Nephrol Dial Transplant. 2019;34:442\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"530_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"530_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcct.2009.12.002","volume":"4","author":"K Nasir","year":"2010","unstructured":"Nasir K, et al. Relationship of aortic valve calcification with coronary artery calcium severity: the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Comput Tomogr. 2010;4:41\u20136.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"530_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.atherosclerosis.2015.10.014","volume":"243","author":"M Henein","year":"2015","unstructured":"Henein M, et al. Aortic root, not valve, calcification correlates with coronary artery calcification in patients with severe aortic stenosis: a two-center study. Atherosclerosis. 2015;243:631\u20137.","journal-title":"Atherosclerosis"},{"key":"530_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/jcm9020607","volume":"9","author":"L Dai","year":"2020","unstructured":"Dai L, et al. Aortic valve calcium associates with all-cause mortality independent of coronary artery calcium and inflammation in patients with end-stage renal disease. J Clin Med. 2020;9:607.","journal-title":"J Clin Med"},{"key":"530_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/STROKEAHA.111.678078","volume":"44","author":"DM Hermann","year":"2013","unstructured":"Hermann DM, et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke. 2013;44:1008\u201313.","journal-title":"Stroke"},{"key":"530_CR21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/archinte.168.12.1333","volume":"168","author":"AR Folsom","year":"2008","unstructured":"Folsom AR, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168:1333\u20139.","journal-title":"Arch Intern Med"},{"key":"530_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.762370","volume":"9","author":"L Wang","year":"2022","unstructured":"Wang L, et al. Prevalence and correlates of cardiovascular calcification and its prognostic effects among patients with chronic kidney disease: results from the C-STRIDE study. Front Public Health. 2022;9: 762370.","journal-title":"Front Public Health"},{"key":"530_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.15420\/ecr.2015.10.2.108","volume":"10","author":"DA Lerman","year":"2015","unstructured":"Lerman DA, Prasad S, Alotti N. Calcific aortic valve disease: molecular mechanisms and therapeutic approaches. Eur Cardiol. 2015;10:108\u201312.","journal-title":"Eur Cardiol"},{"key":"530_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/healthcare9080979","volume":"9","author":"PY Wu","year":"2021","unstructured":"Wu PY, Lee SY, Chang KV, ter Chao C, Huang JW. Gender-related differences in chronic kidney disease-associated vascular calcification risk and potential risk mediators: a scoping review. Healthcare (Basel). 2021;9:979.","journal-title":"Healthcare (Basel)"},{"key":"530_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amjcard.2020.11.026","volume":"142","author":"I Ceponiene","year":"2021","unstructured":"Ceponiene I, et al. Association of coronary calcium, carotid wall thickness, and carotid plaque progression with low-density lipoprotein and high-density lipoprotein particle concentration measured by ion mobility (From Multiethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2021;142:52\u20138.","journal-title":"Am J Cardiol"},{"key":"530_CR26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s11255-020-02498-8","volume":"52","author":"M Tatematsu","year":"2020","unstructured":"Tatematsu M, Inaguma D, Yamada T, Sakamoto I, Sakakibara M. The impact of gender difference on the relationship between serum high-density lipoprotein level and cardiovascular events in incident dialysis patients: a multicenter prospective cohort study. Int Urol Nephrol. 2020;52:1357\u201365.","journal-title":"Int Urol Nephrol"},{"key":"530_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fphar.2020.00564","volume":"11","author":"J Kalibala","year":"2020","unstructured":"Kalibala J, Pech\u00e8re-Bertschi A, Desmeules J. Gender differences in cardiovascular pharmacotherapy\u2014the example of hypertension: a mini review. Front Pharmacol. 2020;11:564.","journal-title":"Front Pharmacol"},{"key":"530_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.csbj.2019.06.015","volume":"17","author":"L Dai","year":"2019","unstructured":"Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P. Early vascular ageing and cellular senescence in chronic kidney disease. Comput Struct Biotechnol J. 2019;17:721.","journal-title":"Comput Struct Biotechnol J"},{"key":"530_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1573402113666170413094319","volume":"13","author":"PG Cunha","year":"2017","unstructured":"Cunha PG, Boutouyrie P, Nilsson PM, Laurent S. Early vascular ageing (EVA): definitions and clinical applicability. Curr Hypertens Rev. 2017;13:8\u201315.","journal-title":"Curr Hypertens Rev"},{"key":"530_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13293-021-00393-0","volume":"12","author":"A Laucyte-Cibulskiene","year":"2021","unstructured":"Laucyte-Cibulskiene A, et al. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality. Biol Sex Differ. 2021;12:50.","journal-title":"Biol Sex Differ"},{"key":"530_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/0886022X.2019.1595646","volume":"41","author":"XR Wang","year":"2019","unstructured":"Wang XR, Zhang JJ, Xu XX, Wu YG. Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2019;41:244\u201356.","journal-title":"Ren Fail"},{"issue":"1","key":"530_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):59. https:\/\/doi.org\/10.1186\/s10020-018-0060-3.","journal-title":"Mol Med"},{"key":"530_CR33","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2337\/diacare.24.9.1620","volume":"24","author":"M Kanauchi","year":"2001","unstructured":"Kanauchi M, Tsujimoto N, Hashimoto T. Advanced glycation end products in nondiabetic patients with coronary artery disease. Diabetes Care. 2001;24:1620\u20133.","journal-title":"Diabetes Care"},{"key":"530_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.thromres.2014.07.008","volume":"134","author":"M Kerkeni","year":"2014","unstructured":"Kerkeni M, et al. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease. Thromb Res. 2014;134:633\u20138.","journal-title":"Thromb Res"},{"key":"530_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ki.5000043","volume":"69","author":"X Wang","year":"2006","unstructured":"Wang X, Desai K, Juurlink BHJ, de Champlain J, Wu L. Gender-related differences in advanced glycation endproducts, oxidative stress markers and nitric oxide synthases in rats. Kidney Int. 2006;69:281\u20137.","journal-title":"Kidney Int"},{"key":"530_CR36","doi-asserted-by":"publisher","first-page":"e83799","DOI":"10.1371\/journal.pone.0083799","volume":"8","author":"K Tanaka","year":"2013","unstructured":"Tanaka K, et al. Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study. PLoS ONE. 2013;8:e83799.","journal-title":"PLoS ONE"},{"key":"530_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000494665","volume":"48","author":"TT Jansz","year":"2018","unstructured":"Jansz TT, et al. Coronary artery calcification in hemodialysis and peritoneal dialysis. Am J Nephrol. 2018;48:369\u201377.","journal-title":"Am J Nephrol"},{"key":"530_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ckj\/sfx124","volume":"11","author":"TT Jansz","year":"2018","unstructured":"Jansz TT, Verhaar MC, London GM, van Jaarsveld BC. Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review. Clin Kidney J. 2018;11:353\u201361.","journal-title":"Clin Kidney J"},{"key":"530_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01963-x","volume":"21","author":"Q Niu","year":"2020","unstructured":"Niu Q, Zhao H, Zuo L, Wang M, Gan L. The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients. BMC Nephrol. 2020;21:1\u20138.","journal-title":"BMC Nephrol"},{"key":"530_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/life11040311","volume":"11","author":"J Chou","year":"2021","unstructured":"Chou J, Kiebalo T, Jagiello P, Pawlaczyk K. Multifaceted sexual dysfunction in dialyzing men and women: pathophysiology, diagnostics, and therapeutics. Life. 2021;11:311.","journal-title":"Life"},{"key":"530_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000458711","volume":"7","author":"D Eckersten","year":"2017","unstructured":"Eckersten D, et al. MicroRNA-155 and anti-m\u00fcllerian hormone: new potential markers of subfertility in men with chronic kidney disease. Nephron Extra. 2017;7:33\u201341.","journal-title":"Nephron Extra"},{"key":"530_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-019-1367-1","volume":"20","author":"M Cano-Meg\u00edas","year":"2019","unstructured":"Cano-Meg\u00edas M, et al. Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study. BMC Nephrol. 2019;20:1\u20139.","journal-title":"BMC Nephrol"},{"key":"530_CR43","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/ndt\/gfy183","volume":"34","author":"MC Lamarche","year":"2019","unstructured":"Lamarche MC, Hopman WM, Garland JS, White CA, Holden RM. Relationship of coronary artery calcification with renal function decline and mortality in predialysis chronic kidney disease patients. Nephrol Dial Transplant. 2019;34:1715\u201322.","journal-title":"Nephrol Dial Transplant"},{"key":"530_CR44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/CS20160047","volume":"130","author":"G Cobo","year":"2016","unstructured":"Cobo G, et al. Sex and gender differences in chronic kidney disease: Progression to end-stage renal disease and haemodialysis. Clin Sci. 2016;130:1147\u201363.","journal-title":"Clin Sci"},{"key":"530_CR45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/08860220500243296","volume":"27","author":"P Str\u00f3zecki","year":"2005","unstructured":"Str\u00f3zecki P, Odrowa\u0327z-Sypniewska G, Manitius J. Cardiac valve calcifications and left ventricular hypertrophy in hemodialysis patients. Ren Fail. 2005;27:733\u20138.","journal-title":"Ren Fail"},{"key":"530_CR46","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.jcmg.2020.02.034","volume":"13","author":"FECM Peeters","year":"2020","unstructured":"Peeters FECM, et al. Sex differences in valve-calcification activity and calcification progression in aortic stenosis. JACC Cardiovasc Imaging. 2020;13:2045\u20136.","journal-title":"JACC Cardiovasc Imaging"},{"key":"530_CR47","doi-asserted-by":"publisher","first-page":"101077","DOI":"10.1016\/j.arr.2020.101077","volume":"61","author":"VA Myasoedova","year":"2020","unstructured":"Myasoedova VA, et al. Sex-specific differences in age-related aortic valve calcium load: a systematic review and meta-analysis. Ageing Res Rev. 2020;61:101077.","journal-title":"Ageing Res Rev"},{"key":"530_CR48","doi-asserted-by":"publisher","first-page":"e015610","DOI":"10.1161\/JAHA.119.015610","volume":"9","author":"M Voisine","year":"2020","unstructured":"Voisine M, et al. Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc. 2020;9:e015610.","journal-title":"J Am Heart Assoc"},{"key":"530_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fcell.2020.00604","volume":"8","author":"FECM Peeters","year":"2020","unstructured":"Peeters FECM, et al. Biomarkers associated with aortic valve calcification: should we focus on sex specific processes? Front Cell Dev Biol. 2020;8:604.","journal-title":"Front Cell Dev Biol"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00530-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-023-00530-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00530-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:05:31Z","timestamp":1689271531000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-023-00530-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1186\/s13293-023-00530-x","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Ethics Committee (EPN), Stockholm, Sweden, approved the study protocols that were performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}